These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 20477505)

  • 1. Lymphocyte proteomics of Parkinson's disease patients reveals cytoskeletal protein dysregulation and oxidative stress.
    Mila S; Albo AG; Corpillo D; Giraudo S; Zibetti M; Bucci EM; Lopiano L; Fasano M
    Biomark Med; 2009 Apr; 3(2):117-28. PubMed ID: 20477505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subthalamic nucleus stimulation modulates motor cortex oscillatory activity in Parkinson's disease.
    Devos D; Labyt E; Derambure P; Bourriez JL; Cassim F; Reyns N; Blond S; Guieu JD; Destée A; Defebvre L
    Brain; 2004 Feb; 127(Pt 2):408-19. PubMed ID: 14691060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A proteomic approach in the study of an animal model of Parkinson's disease.
    De Iuliis A; Grigoletto J; Recchia A; Giusti P; Arslan P
    Clin Chim Acta; 2005 Jul; 357(2):202-9. PubMed ID: 15946658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilateral subthalamic nucleus stimulation for Parkinson's disease: a systematic review of the clinical literature.
    Hamani C; Richter E; Schwalb JM; Lozano AM
    Neurosurgery; 2008 Feb; 62 Suppl 2():863-74. PubMed ID: 18596421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of basal ganglia on upper limb locomotor synergies. Evidence from deep brain stimulation and L-DOPA treatment in Parkinson's disease.
    Crenna P; Carpinella I; Lopiano L; Marzegan A; Rabuffetti M; Rizzone M; Lanotte M; Ferrarin M
    Brain; 2008 Dec; 131(Pt 12):3410-20. PubMed ID: 18952669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus.
    Spottke EA; Volkmann J; Lorenz D; Krack P; Smala AM; Sturm V; Gerstner A; Berger K; Hellwig D; Deuschl G; Freund HJ; Oertel WH; Dodel RC
    J Neurol; 2002 Jun; 249(6):759-66. PubMed ID: 12111311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired cardiovascular autonomic control in newly and long-term-treated patients with Parkinson's disease: involvement of L-dopa therapy.
    Bouhaddi M; Vuillier F; Fortrat JO; Cappelle S; Henriet MT; Rumbach L; Regnard J
    Auton Neurosci; 2004 Nov; 116(1-2):30-8. PubMed ID: 15556835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and pharmacodynamic comparison of ropinirole 24-hour prolonged release and ropinirole immediate release in patients with Parkinson's disease.
    Tompson D; Oliver-Willwong R
    Clin Neuropharmacol; 2009; 32(3):140-8. PubMed ID: 18978485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of body weight gain in patients with Parkinson's disease after subthalamic stimulation.
    Montaurier C; Morio B; Bannier S; Derost P; Arnaud P; Brandolini-Bunlon M; Giraudet C; Boirie Y; Durif F
    Brain; 2007 Jul; 130(Pt 7):1808-18. PubMed ID: 17535833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral blood markers of oxidative stress in Parkinson's disease.
    Younes-Mhenni S; Frih-Ayed M; Kerkeni A; Bost M; Chazot G
    Eur Neurol; 2007; 58(2):78-83. PubMed ID: 17565220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-dopa-induced dyskinesia and stereotactic surgery for Parkinson's disease.
    Guridi J; Obeso JA; Rodriguez-Oroz MC; Lozano AA; Manrique M
    Neurosurgery; 2008 Feb; 62(2):311-23; discussion 323-5. PubMed ID: 18382309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of subthalamic nucleus stimulation and L-dopa in trunk kinematics of patients with Parkinson's disease.
    Ferrarin M; Rizzone M; Lopiano L; Recalcati M; Pedotti A
    Gait Posture; 2004 Apr; 19(2):164-71. PubMed ID: 15013505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of deep brain stimulation and L-Dopa on electrocortical rhythms related to movement in Parkinson's disease.
    Devos D; Defebvre L
    Prog Brain Res; 2006; 159():331-49. PubMed ID: 17071241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism.
    Plaha P; Ben-Shlomo Y; Patel NK; Gill SS
    Brain; 2006 Jul; 129(Pt 7):1732-47. PubMed ID: 16720681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia.
    Stoffers D; Bosboom JL; Deijen JB; Wolters EC; Berendse HW; Stam CJ
    Brain; 2007 Jul; 130(Pt 7):1847-60. PubMed ID: 17412733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of differentially displayed proteins in cerebrospinal fluid of Parkinson's disease patients: a proteomic approach.
    Sinha A; Srivastava N; Singh S; Singh AK; Bhushan S; Shukla R; Singh MP
    Clin Chim Acta; 2009 Feb; 400(1-2):14-20. PubMed ID: 18977210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphism of the angiotensin converting enzyme and L-dopa-induced adverse effects in Parkinson's disease.
    Lin JJ; Yueh KC; Lin SZ; Harn HJ; Liu JT
    J Neurol Sci; 2007 Jan; 252(2):130-4. PubMed ID: 17196621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved asymmetry of gait in Parkinson's disease with DBS: gait and postural instability in Parkinson's disease treated with bilateral deep brain stimulation in the subthalamic nucleus.
    Johnsen EL; Mogensen PH; Sunde NA; Østergaard K
    Mov Disord; 2009 Mar; 24(4):590-7. PubMed ID: 19097189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma lipid peroxidation in sporadic Parkinson's disease. Role of the L-dopa.
    Agil A; Durán R; Barrero F; Morales B; Araúzo M; Alba F; Miranda MT; Prieto I; Ramírez M; Vives F
    J Neurol Sci; 2006 Jan; 240(1-2):31-6. PubMed ID: 16219327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.